Expression of miR‑34a and Ki67 in nasopharyngeal carcinoma and the relationship with clinicopathological features and prognosis

Wei,Linqi; Shi,Chao; Zhang,Yonghong

doi:10.3892/ol.2019.11217

Expression of miR‑34a and Ki67 in nasopharyngeal carcinoma and the relationship with clinicopathological features and prognosis

Authors:
- Linqi Wei
- Chao Shi
- Yonghong Zhang
View Affiliations

Affiliations: Department of Otolaryngology, Head and Neck Surgery, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China
Published online on: December 13, 2019 https://doi.org/10.3892/ol.2019.11217
Pages: 1273-1280
Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Expression levels of miR‑34a and Ki67 in nasopharyngeal carcinoma (NPC) and the relationship with clinicopathological features and prognosis were studied. A prospective study was performed on 56 cases of NPC tissues and 56 cases of adjacent tissues collected in Xiangyang No. 1 People's Hospital. The expression levels of miR‑34a, Ki67 in NPC and adjacent tissues were detected by RT‑qPCR. The association among the expression levels of miR‑34a and Ki67, the clinicopathological features and prognosis of patients was analyzed. The relative expression levels of miR‑34a in 56 cases of NPC were lower than those of the adjacent tissues. The expression of miR‑34a in NPC was significantly associated with bone metastasis and TNM staging (P<0.001). The relative expression of Ki67 in 56 cases of NPC was higher than that of the adjacent tissues. The expression of Ki67 in NPC was significantly associated with lymphatic metastasis and TNM staging (P<0.001). The 5‑year survival of patients with low expression of miR‑34a was significantly lower than that of patients with high expression, and the survival of patients with high expression of Ki67 was significantly lower than that of patients with low expression. According to Pearson's correlation analysis, Ki67 expression was negatively correlated with miR‑34a expression in NPC tissues. In conclusion, the expression of Ki67 in NPC was upregulated, while the expression of miR‑34a in NPC was downregulated. miR‑34a expression in NPC was significantly associated with bone metastasis and TNM staging, and Ki67 expression in NPC was significantly associated with lymphatic metastasis and TNM staging. In addition, there was a negative correlation between miR‑34a and Ki67 expression levels, and the two can be used as predictors of NPC‑associated mortality. The expression levels of miR‑34a and Ki67, as well as TNM staging were associated with the prognosis of NPC patients.

View Figures

View References

1	Paul P, Deka H, Malakar AK, Halder B and Chakraborty S: Nasopharyngeal carcinoma: Understanding its molecular biology at a fine scale. Eur J Cancer Prev. 27:33–41. 2018. View Article : Google Scholar : PubMed/NCBI
2	Fu ZT, Guo XL, Zhang SW, Zeng HM, Sun KX, Chen WQ and He J: Incidence and mortality of nasopharyngeal carcinoma in China, 2014. Zhonghua Zhong Liu Za Zhi. 40:566–571. 2018.(In Chinese). PubMed/NCBI
3	Kong L, Li X, Wang H, He G and Tang A: Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways. Biomed Pharmacother. 106:342–348. 2018. View Article : Google Scholar : PubMed/NCBI
4	Huang WB, Chan JYW and Liu DL: Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China. Cancer. 124:530–536. 2018. View Article : Google Scholar : PubMed/NCBI
5	Fangzheng W, Chuner J, Lei W, Weijun C, Min X, Quanquan S, Tongxin L, Aizawa R, Sakamoto M and Zhenfu F: Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma. Oncotarget. 8:39756–39765. 2017. View Article : Google Scholar : PubMed/NCBI
6	Wu LR, Liu YT, Jiang N, Fan YX, Wen J, Huang SF, Guo WJ, Bian XH, Wang FJ, Li F, et al: Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center. Oral Oncol. 69:26–32. 2017. View Article : Google Scholar : PubMed/NCBI
7	Zhou Y, Xia L, Lin J, Wang H, Oyang L, Tan S, Tian Y, Su M, Wang H, Cao D, et al: Exosomes in nasopharyngeal carcinoma. J Cancer. 9:767–777. 2018. View Article : Google Scholar : PubMed/NCBI
8	Witwer KW and Halushka MK: Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research. RNA Biol. 13:1103–1116. 2016. View Article : Google Scholar : PubMed/NCBI
9	Cheng C, Xiaohua W, Ning J, Dan Z, Chengyun Y, Lijun Z, Li Y, Shengfu H, Hong J and He X: MiR-122 exerts anti-proliferative and apoptotic effects on nasopharyngeal carcinoma cells via the PI3K/AKT signaling pathway. Cell Mol Biol. 64:21–25. 2018. View Article : Google Scholar : PubMed/NCBI
10	Chen L, Gao H, Liang J, Qiao J, Duan J, Shi H, Zhen T, Li H, Zhang F, Zhu Z, et al: miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D. Am J Cancer Res. 8:2387–2401. 2018.PubMed/NCBI
11	Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, Liang J and Zhang Y: Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 36:209–220. 2018. View Article : Google Scholar : PubMed/NCBI
12	Yang C, Zhang J, Ding M, Xu K, Li L, Mao L and Zheng J: Ki67 targeted strategies for cancer therapy. Clin Transl Oncol. 20:570–575. 2018. View Article : Google Scholar : PubMed/NCBI
13	Zhang J, Liu Y, Deng Y, He J, Lang J and Fan J: Ki67 and nm23 are potential prognostic markers in patients with nasopharyngeal carcinoma. Int J Clin Exp Pathol. 9:6350–6356. 2016.
14	Chen Q, Guo Z, Liu S, Quan P, Cao X, Guo L, Zhang S and Sun X: The cancer incidence and mortality among children and adolescents during the period of 2010–2014 in Henan Province, China. Cancer Med. 8:814–823. 2019. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, Peng W and Yang XB: Coptidis Rhizoma: A comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol. 57:193–225. 2019. View Article : Google Scholar : PubMed/NCBI
17	DeBord LC, Pathak RR, Villaneuva M, Liu HC, Harrington DA, Yu W, Lewis MT and Sikora AG: The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research. Am J Cancer Res. 8:1642–1660. 2018.PubMed/NCBI
18	Zhang J, Jia L, Tsang CM and Tsao SW: EBV infection and glucose metabolism in nasopharyngeal carcinoma. Adv Exp Med Biol. 1018:75–90. 2017. View Article : Google Scholar : PubMed/NCBI
19	Fangzheng W, Chuner J, Quanquan S, Zhimin Y, Tongxin L, Jiping L, Sakamoto M, Peng W, Kaiyuan S, Weifeng Q, et al: Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients. J Cancer. 9:2030–2037. 2018. View Article : Google Scholar : PubMed/NCBI
20	Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
21	Huang G, Du MY, Zhu H, Zhang N, Lu ZW, Qian LX, Zhang W, Tian X, He X and Yin L: MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells. Biomed Pharmacother. 106:217–224. 2018. View Article : Google Scholar : PubMed/NCBI
22	Klöppel G and La Rosa S: Ki67 labeling index: Assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms. Virchows Arch. 472:341–349. 2018. View Article : Google Scholar : PubMed/NCBI
23	Shan GP, Wang BB, Zheng P, Du FL and Yang YW: Efficacy and safety of chemotherapy combined with stereotactic radiotherapy in the treatment of nasopharyngeal carcinoma. Med Sci Monit. 23:5630–5636. 2017. View Article : Google Scholar : PubMed/NCBI
24	Guan GF, Zhang DJ, Wen LJ, Yu DJ, Zhao Y, Zhu L, Guo YY and Zheng Y: Prognostic value of TROP2 in human nasopharyngeal carcinoma. Int J Clin Exp Pathol. 8:10995–11004. 2015.PubMed/NCBI
25	Zhao L, Chen H, Hu B, Zhang H and Lin Q: Prognostic significance of Ki67 expression and the derived neutrophil-lymphocyte ratio in nasopharyngeal carcinoma. Cancer Manag Res. 10:1919–1926. 2018. View Article : Google Scholar : PubMed/NCBI
26	Zhao Y and Shen L, Huang X, Jing D, Huang D, Fu J, Li Z, Zhang G and Shen L: High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma. Biochem Biophys Res Commun. 494:390–396. 2017. View Article : Google Scholar : PubMed/NCBI